Automated cell manufacturing company Mytos has partnered with Aspen Neuroscience to automate the production of customized cells for Aspen’s Parkinson’s disease therapy. Under the agreement, Aspen will use Mytos’s iDEM technology to manage cell production in its California-based factory. The deal allows Aspen to streamline its cell production process, reducing labor and enabling multibatch handling to increase capacity. A manual iDEM alternative can be learned by a single operator.

North Korean Hackers Use Fake U.S. Companies to Spread Malware in Crypto Industry: Report
North Korean hackers reportedly set up shell companies in the US to penetrate the crypto sector and target developers via fake job offers, according to